Remy Cointreau Shares Climb 2.6% Midday
On Wednesday, January 21, Remy Cointreau's stock price increased by 2.62% to 40.02 euros around noon, after closing at 39 euros the previous day. This rebound occurs as the spirits specialist attempts to recover from a challenging year, marked by a 28.6% decline. The cognac and liqueur producer continues to face cyclical difficulties in its two strategic markets, China and the United States.
Analyst Opinions Show Mixed Views
Recent analyst opinions present a mixed outlook on the stock. Goldman Sachs raised its price target from 48 to 50 euros on January 9 while maintaining a neutral recommendation, offering a potential upside of 25% from the current stock level. Conversely, Barclays adjusted its target from 34 to 35 euros with an underweight recommendation, reflecting caution about the company's prospects. This divergence underscores the ongoing uncertainty regarding the recovery of the business. The operational context remains complex for the maker of Remy Martin. In the first half of fiscal 2025-2026 ending in late September, recurring operating income fell by 26.2% year-on-year to 108.7 million euros, and recurring net income declined by more than 30%. The group has lowered its forecasts for its staggered fiscal year 2025-2026, citing deteriorating market conditions in China and a less robust rebound in activity in the United States than expected. This downward revision of targets fuels skepticism among some financial intermediaries.
Technical Indicators Show Signs of Stabilization
From a technical perspective, Remy Cointreau shows signs of stabilization after a challenging year in 2025. The price is now trading above its 50-day moving average of 38.91 euros, indicating a short-term momentum gain. The RSI is at 64, close to the neutrality zone but still below the overbought threshold, leaving room for technical progression. However, key levels remain under watch. The major resistance is positioned at 41.58 euros, a level that could hinder the stock's progress in case of a sustained recovery. On the downside, the support at 35.38 euros serves as a safety net that operators monitor closely. The monthly volatility of 10.31% and a negative beta of -0.07 illustrate an atypical behavior of the stock in response to market movements. Trading volumes remain modest with only 0.06% of the capital traded this Wednesday, signaling a cautious wait from investors ahead of the quarterly earnings release scheduled for January 29.
